13F Holdings
中文EN

UHS UNIVERSAL HEALTH SERVICES INC

Services-General Medical & Surgical Hospitals, NEC · NYSE · SEC CIK 352915 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY8.0%
TTM net income YoY6.3%
TTM EPS YoY13.7%
Revenue 3-yr CAGR9.4%
Net income 3-yr CAGR29.3%

Margins

Gross margin—
Operating margin10.8%
Net margin8.0%
FCF margin6.1%
EBITDA margin14.5%

Returns

ROE19.8%
ROA9.0%
ROIC (approx.)12.2%
Asset turnover1.13x

Leverage & solvency

Liabilities / assets55.0%
Debt / equity0.75x
Current ratio1.37x
Interest coverage11.34x

Cash quality & payout

Operating cash flow / net income1.41x
Accruals ratio-3.7%
Payout ratio3.3%
Capex / revenue5.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$17.36B$15.83B$14.28B$13.40B$12.64B
Operating income$1.99B$1.68B$1.18B$1.00B$1.36B
Interest expense$156.07M$186.11M$206.67M$126.89M$83.67M
Pretax income$1.97B$1.50B$940.43M$866.26M$1.29B
Income tax$460.96M$334.83M$221.12M$209.28M$305.68M
Net income$1.49B$1.14B$717.79M$675.61M$991.59M
EBITDA$2.61B$2.27B$1.74B$1.59B$1.90B
EPS (basic)23.4217.1610.359.2311.99
EPS (diluted)23.1016.8210.239.1411.82
Dividends declared per share0.800.800.800.800.80
Weighted avg. shares (diluted)64.46M67.90M70.12M73.83M83.69M
Balance sheet
Cash & equivalents$137.80M$125.98M$119.44M$102.82M$115.30M
Receivables$2.60B$2.18B$2.24B$2.02B$1.75B
Current assets$3.41B$2.82B$2.81B$2.54B$2.26B
PP&E, net$7.01B$6.57B$6.12B$5.92B$5.87B
Goodwill$3.99B$3.93B$3.93B$3.91B$3.96B
Intangibles$75.88M$76.27M$77.02M$78.10M$81.04M
Total assets$15.53B$14.47B$13.97B$13.49B$13.09B
Current liabilities$3.24B$2.21B$2.01B$1.91B$1.98B
Short-term debt$748.16M$40.06M$126.69M$81.45M$48.41M
Long-term debt$4.00B$4.46B$4.79B$4.73B$4.14B
Total debt$4.75B$4.50B$4.91B$4.81B$4.19B
Total liabilities$8.12B$7.71B$7.77B$7.52B$6.90B
Shareholders' equity$7.28B$6.67B$6.15B$5.92B$6.09B
Net debt$4.61B$4.38B$4.79B$4.71B$4.07B
Cash flow statement
Operating cash flow$1.86B$2.07B$1.27B$996.02M$883.70M
Capital expenditure$1.02B$943.81M$743.05M$734.00M$855.66M
Free cash flow$849.25M$1.12B$524.74M$262.02M$28.04M
Investing cash flow-$1.07B-$911.11M-$763.27M-$647.30M-$914.47M
Financing cash flow-$749.73M-$1.14B-$493.94M-$318.40M-$1.07B
Depreciation & amortization$618.74M$584.83M$568.04M$581.86M$533.21M
Stock-based compensation$95.69M$99.35M$87.72M$85.38M$73.69M
Dividends paid$51.27M$53.35M$55.48M$58.45M$65.90M
Share buybacks$967.95M$670.75M$547.36M$832.92M$1.22B

Free plan shows the latest 5 periods; Pro shows all 18 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.